BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Confirms Approach to Sofdra NDA Resubmission, page-3

  1. 417 Posts.
    lightbulb Created with Sketch. 66
    well no indication from the FDA of a potential earlier approval date. Suffice to say SP will hang around these levels for the next 6 months
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.